We are looking for young people 2–17 years of age to join a CD trial to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Crohn’s disease (CD) (including associated symptoms such as diarrhea with blood, mouth sores, rectal pain, frequent fevers and/or canker sores), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the UC studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
